
手機掃碼訪問本站

微信咨詢
猜你喜歡
- 33419-42-0 / 新型抗腫瘤藥物-依托泊苷
- DIETHYLGERMANE
- 4-(4-acetamido-1-methyl-1H-imidazole-2-carboxamido)-1-methyl-1H-imidazole-2-carboxylic acid
- ETHYL 4-[2-[8-(1,4-DIOXA-8-AZASPIRO[4.5]DECYL)METHYL]PHENYL]-4-OXOBUTYRATE
- 3-(2-溴乙基)噻吩
- 環己酮對甲苯磺酰腙
- 草酸鋰
- N-(2-CHLOROETHYL)-N’-[4-(METHYLSULFANYL)PHENYL]UREA
- D-[1,2,3,3′-2H4]GLYCERALDEHYDE
- 1-(1-甲基-1H-吡唑-4-基)乙胺
- 1,3-雙三氟丙基-1,1,3,3-四甲基二硅代氧烷
- N-乙基-2-吡啶甲胺
- 生育酚乙酸酯
- 3-(3-FLUOROBENZOYL)THIOPHENE
- 1-benzyl-3,5-dichloro-1H-1,2,4-triazole(SALTDATA: FREE)
- 1,2,3,4-TETRAOXO-1,2,3,4-TETRAHYDRONAPHTHALENE DIHYDRATE
- 奈韋拉平相關物質B
- 3-甲基-2-氧代丁酰乙酯
- 57644-54-9/為你介紹枸櫞酸鉍鉀給藥護理要點
- 2-乙?;?3-(二甲基氨基)丙烯酸乙酯
- 二水碲酸
- 3-(4-ACETOXYPHENYL)-1-PROPENE
- 3′-BROMO-3-(2-METHYLPHENYL)PROPIOPHENONE
- 4-羥甲基哌啶-4-醇
- 23651-95-8 / 屈昔多巴雜質A的合成方法